Literature DB >> 17273726

Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patients.

Verena Materna1, Pawel Surowiak, Ewa Markwitz, Marek Spaczynski, Malgorzata Drag-Zalesinska, Maciej Zabel, Hermann Lage.   

Abstract

A major obstacle in treatment of ovarian cancer is intrinsic or acquired drug resistance causing failure of chemotherapy followed by a poor clinical outcome. Drug resistance of ovarian carcinoma can be caused by dysregulation of cellular factors involved in regulation of apoptosis and DNA repair pathways. In this study, 73 ovarian carcinoma specimens obtained before and after chemotherapy were analysed by immunohistochemistry for expression of seven proteins playing an important role in regulation of DNA mismatch repair and apoptosis. The prognostic significance of these proteins in the meaning of overall and progression-free survival was evaluated in univariate and multivariate analysis. Bcl-xL, hMSH2, caspase-3, p21 and p53 displayed prognostic importance in univariate analysis. Furthermore, it was demonstrated that caspase-3 and p21 were also independent prognostic markers for both, overall and progression-free survival. In conclusion, these data indicate that analysis of proteins involved in DNA mismatch repair and apoptosis can be useful for prediction of clinical outcome in ovarian carcinoma patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273726

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

Review 1.  Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies.

Authors:  Linjuan Xu; Jing Cai; Qiang Yang; Hui Ding; Liying Wu; Tao Li; Zehua Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-18       Impact factor: 4.553

Review 2.  Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.

Authors:  Marieke A Vollebergh; Jos Jonkers; Sabine C Linn
Journal:  Cell Mol Life Sci       Date:  2011-09-16       Impact factor: 9.261

3.  Enhanced immunoreactivity of TIMP-2 in the stromal compartment of tumor as a marker of favorable prognosis in ovarian cancer patients.

Authors:  Agnieszka Hałoń; Ewa Nowak-Markwitz; Piotr Donizy; Rafal Matkowski; Adam Maciejczyk; Tserenchunt Gansukh; Balázs Györffy; Marek Spaczyński; Maciej Zabel; Hermann Lage; Pawel Surowiak
Journal:  J Histochem Cytochem       Date:  2012-04-17       Impact factor: 2.479

4.  Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression.

Authors:  Fengkun Du; Yan Li; Wensheng Zhang; Shubha P Kale; Harris McFerrin; Ian Davenport; Guangdi Wang; Elena Skripnikova; Xiao-Lin Li; Nathan J Bowen; Leticia B McDaniels; Yuan-Xiang Meng; Paula Polk; Yong-Yu Liu; Qian-Jin Zhang
Journal:  Tumour Biol       Date:  2016-03-02

5.  RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers.

Authors:  Christophe Lemetre; Begoña Vieites; Charlotte K Y Ng; Salvatore Piscuoglio; Anne M Schultheis; Caterina Marchiò; Rajmohan Murali; Maria A Lopez-García; Jose C Palacios; Achim A Jungbluth; Luigi M Terracciano; Jorge S Reis-Filho; Britta Weigelt
Journal:  Eur J Cancer       Date:  2016-07-14       Impact factor: 9.162

6.  Control of cellular Bcl-xL levels by deamidation-regulated degradation.

Authors:  So Hee Dho; Benjamin E Deverman; Carlo Lapid; Scott R Manson; Lu Gan; Jacob J Riehm; Rajeev Aurora; Ki-Sun Kwon; Steven J Weintraub
Journal:  PLoS Biol       Date:  2013-06-25       Impact factor: 8.029

7.  Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death.

Authors:  François Fabi; Pascal Adam; Keven Vincent; Françis Demontigny; Sophie Parent; France-Hélène Joncas; Eric Asselin
Journal:  Cell Commun Signal       Date:  2018-07-04       Impact factor: 5.712

8.  Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis.

Authors:  P de Graeff; A P G Crijns; S de Jong; M Boezen; W J Post; E G E de Vries; A G J van der Zee; G H de Bock
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

9.  Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.

Authors:  Cécile Le Page; David G Huntsman; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Cancers (Basel)       Date:  2010-05-26       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.